Poor Outcomes Among Pediatric Non-Down Syndrome Acute Megakaryocytic Leukemia Patients Irrespective of Receipt of Hematopoietic Stem Cell Transplant

MLA

Llaurador, Gabriela, et al. “Poor Outcomes Among Pediatric Non-Down Syndrome Acute Megakaryocytic Leukemia Patients Irrespective of Receipt of Hematopoietic Stem Cell Transplant.” Blood, vol. 140, no. Supplement 1, Nov. 2022, pp. 10632–33. EBSCOhost, https://doi.org/10.1182/blood-2022-167487.

APA

Llaurador, G., Willis, M., Redell, M., Gramatges, M. M., Naik, S., Krance, R. A., Doherty, E. E., & Stevens, A. M. (2022). Poor Outcomes Among Pediatric Non-Down Syndrome Acute Megakaryocytic Leukemia Patients Irrespective of Receipt of Hematopoietic Stem Cell Transplant. Blood, 140(Supplement 1), 10632–10633. https://doi.org/10.1182/blood-2022-167487

Chicago

Llaurador, Gabriela, Matthew Willis, Michele Redell, M Monica Gramatges, Swati Naik, Robert A. Krance, Erin E Doherty, and Alexandra McLean Stevens. 2022. “Poor Outcomes Among Pediatric Non-Down Syndrome Acute Megakaryocytic Leukemia Patients Irrespective of Receipt of Hematopoietic Stem Cell Transplant.” Blood 140 (Supplement 1): 10632–33. doi:10.1182/blood-2022-167487.